Morgan Stanley logo MS - Morgan Stanley

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 29
HOLD 23
SELL 1
STRONG
SELL
0
| PRICE TARGET: $212.00 DETAILS
HIGH: $236.00
LOW: $195.00
MEDIAN: $208.50
CONSENSUS: $212.00
UPSIDE: 17.43%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 90% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Fair Value Mild
Trading 12.7% below fair value
Current Price $180.54
Bear Case $144.69 19.9% downside ($144.69 - $180.54) / $180.54 = -19.9% ROTCE 14.2% → 1.47x TBV
Fair Value $206.70 14.5% upside ($206.70 - $180.54) / $180.54 = 14.5% ROTCE 19.0% → 2.15x TBV
Bull Case $268.71 48.8% upside ($268.71 - $180.54) / $180.54 = 48.8% ROTCE 21.8% → 2.55x TBV

Adjust Assumptions

19.0%
11.0%

Key Value Driver

ROTCE (19.0%) vs. cost of equity (11.0%)

Implied Market Multiple 3.2x

Plain-Language Summary

With ROTCE of 19.0% vs. 11.0% cost of equity, fair P/TBV is 2.15x on $56.36 tangible book, implying $206.70 per share. DDM cross-check: $147.21.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (53 analysts) $212.00
Analyst Range $195.00 – $236.00
Divergence from AlphaVal 3%

Warnings

⚠ Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
⚠ Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
ℹ Dividend-based valuation: $147.21 (29% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly